Clinical Trial Update: GnRH Agonist at Embryo Transfer: IVF Outcomes [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating GnRH agonist use at embryo transfer in IVF has been withdrawn from the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• GnRH agonist (gonadotropin-releasing hormone agonist)

Snippet

Sponsor: Maimonides Medical Center | Conditions: Infertility, Infertility, Female | Phase 3 | Status: WITHDRAWN